CURRENT FUNDING
1/2017 - 10/2017 Co-Investigator (PI: Ethan Balk). World Health Organization. Conducting Systematic Reviews to inform WHO Guidelines on the Clinical Management of Cancer Pain. The objective of this proposal was to conduct a systematic review to inform the development of new cancer pain guidelines.
1/2017 - 12/2017 Co-Investigator (PI: Safiya Naidjate). American Society of Health-System Pharmacists (ASHP) Research and Education Foundation. Resident Practice-Based Research Grant. Outcomes of a Pharmacist-Managed Hepatitis C Virus Clinic Care Delivery Model. The objectives of this proposal are: 1) to describe the demographic, clinical, and social characteristics of adult patients infected with HCV at a pharmacist-managed outpatient HCV clinic, 2) to characterize the determinants of enrollment in a pharmacist-managed outpatient HCV clinic versus a limited-pharmacist- involvement clinic for HCV patients, and 3) to estimate the effect of a pharmacist-managed HCV clinic versus a limited-pharmacist- involvement clinic on treatment completion and achieving HCV cure.
9/2015 - 9/2017 Scholar (PI: Thomas Trikalinos). Agency for Healthcare Research and Quality (5K12HS022998-02). Develop Patient Centered Outcomes Scholars for Comparative Effectiveness Research. The objective of this award is to prepare scholars to apply comparative effectiveness research methods to patient-centered outcomes research.
8/2014 - 4/2018 Co-Investigator (PI: Sarah Berry). National Institute on Aging (5R01AG045441-02). A Clinical Prediction Tool to Guide Treatment of Osteoporosis in the Nursing Home. The objective of this award is to develop a screening tool for osteoporosis and use the screening tool to determine a threshold at which osteoporosis medications prevent fractures.
PAST FUNDING
1/2016 - 12/2016 Co-Investigator (PI: Laura McAuliffe). American Society of Health-System Pharmacists (ASHP) Research and Education Foundation. Resident Practice-Based Research Grant. Identification of Pharmacy Transitions of Care Patients at Highest Risk of 30-Day Hospital Readmission. The objectives of this award are 1) to identify factors associated with an increased risk of unplanned hospital readmission, paying particular attention to factors that a) frequently available to the transitions of care pharmacist, and b) unavailable in previous models of rehospitalization developed by other researchers using administrative claims data, and 2) develop and validate a practical prediction tool for use by transitions of care pharmacists.
5/2015 - 8/2015 Principal Investigator. Population Studies and Training Center of Brown University. The objective of this study is to extend and apply doubly estimation of causal effects for complex survey data to estimate the effect of health insurance on personal prescription drug importation behavior.
1/2015 - 1/2016 Principal Investigator. Nora Kahn Piore Award. The objective of this study is to use state-of-the-art quantitative methods for causal inference, specifically inverse probability weighted (IPW) marginal structural models (MSMs), in complex survey data to estimate the unconditional effect of health insurance on the risk of PPDI across subpopulations of the United States defined by important characteristics.
9/2014 - 5/2015 Principal Investigator. Brown University Sheridan Center for Teaching and Learning. The objective of this study is to preliminarily test the feasibility and acceptability of a highly innovative conditional economic incentives program to incentivize healthy behaviors among HIV-positive men in Mexico City.
5/2014 - 8/2014 Principal Investigator. Population Studies and Training Center of Brown University. The objective of this study is to extend novel causal inference methods for complex survey data to estimate the effect of policy interventions on personal prescription drug importation behavior.
8/2013 - 6/2016 Research Assistant, then Co-Investigator (PI: Michael Steinman). National Heart, Lung, and Blood Institute (5R01HL111032-03). Outcomes of Beta Blockers after Myocardial Infarction in Nursing Home Residents. The objective of this award is to better understand the benefits and harms of beta blockers in frail nursing home residents after myocardial infarction to substantially improve the evidence base and help guide treatment decisions for this important population.
